diabetic retinopathy is the leading cause of blindness in the world. strict control of blood sugar, blood pressure, laser therapy, pharmacotherapy and vitrectomy are of among common diabetic retinopathy treatments. further studies to investigate the effect of protein kinase c inhibitors, angiotensin converting enzyme inhibitors, growth hormone and other proposed treatments for diabetic retinopa...

PURPOSE To investigate macular thickness and visual acuity changes after 1 intravitreal injection of 0.5-mg ranibizumab during phacoemulsification cataract surgery in eyes with diabetic macular edema refractory to laser treatment. METHODS Eleven eyes of 11 patients with diabetic macular edema refractory to modified Early Treatment Diabetic Retinopathy Study laser therapy received intravitreal...

 Background: Diabetes is a common metabolic disorder leading to the development of many complications, among which diabetic retinopathy and macular edema are the most significant. These complications can contribute to blindness if not diagnosed or treated properly, and several studies have been conducted to evaluate the methods for the prevention or slowing down their progression. Ther...

purpose:  to determine whether angiotensin ii levels in aqueous humor is related to diabetes mellitus and to evaluate the effect of captopril. methods: in a case-control study, aqueous humor samples were obtained during cataract surgery from 58 eyes of 58 patients, of which 37 were diabetic. from these latter subjects, 16 had taken captopril (captopril group) and 21 had not taken any angiotensi...

purpose: to evaluate the effectiveness of pars plana vitrectomy and posterior hyaloid stripping in decreasing macular thickness and improving vision in diabetic macular edema.          methods: this prospective interventional case series includes 30 eyes of 25 diabetic patients with diabetic macular edema with macular thickness exceeding 170 microns and thickened posterior hyaloid. bcva and mac...

PURPOSE To determine whether or not a sub-Tenon's capsule injection of triamcinolone acetonide(TA) is an effective treatment for refractory diabetic macular edema after vitrectomy. METHODS Thirty-nine eyes of 26 patients with diabetic macular edema were injected with 20 mg TA into the sub-Tenon's capsule. The central macular thickness (CMT) measured by an optical coherence tomography (OCT) an...

purpose: to evaluate the effects of posterior subtenon triamcinolone acetonide (ta) injection on clinical, angiographic, and optical coherence tomographic (oct) features in refractory diabetic macular edema (dme). method: in a randomized double-masked placebo-controlled clinical trial, 38 consecutive patients (64 eyes) with dme refractory to previous laser therapy or not suitable for such treat...

background: diabetes is a common metabolic disorder leading to the development of many complications, among which diabetic retinopathy and macular edema are the most significant. these complications can contribute to blindness if not diagnosed or treated properly, and several studies have been conducted to evaluate the methods for the prevention or slowing down their progression. therefore, ser...

purpose: to determine the effect of grid pattern laser photocoagulation on diabetic diffuse macular edema with assessment of visual outcome. patients & methods: the author reviewed the medical records of 84 eyes of 62 patients with diabetic diffuse macular edema treated with grid pattern green argon laser photocoagulation in farabi eye hospital between the years 1992-1995, the follow-up period ...